PL2621513T3 - Ekspresja receptora eph w nowotworowych komórkach macierzystych - Google Patents
Ekspresja receptora eph w nowotworowych komórkach macierzystychInfo
- Publication number
- PL2621513T3 PL2621513T3 PL11778540T PL11778540T PL2621513T3 PL 2621513 T3 PL2621513 T3 PL 2621513T3 PL 11778540 T PL11778540 T PL 11778540T PL 11778540 T PL11778540 T PL 11778540T PL 2621513 T3 PL2621513 T3 PL 2621513T3
- Authority
- PL
- Poland
- Prior art keywords
- stem cells
- receptor expression
- tumor stem
- eph receptor
- eph
- Prior art date
Links
- 102000050554 Eph Family Receptors Human genes 0.000 title 1
- 108091008815 Eph receptors Proteins 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 210000000130 stem cell Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10185930A EP2446895A1 (en) | 2010-10-01 | 2010-10-01 | EPH receptor expression in tumor stem cells |
| EP11778540.2A EP2621513B1 (en) | 2010-10-01 | 2011-09-30 | Eph receptor expression in tumor stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2621513T3 true PL2621513T3 (pl) | 2017-06-30 |
Family
ID=43856109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11778540T PL2621513T3 (pl) | 2010-10-01 | 2011-09-30 | Ekspresja receptora eph w nowotworowych komórkach macierzystych |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9078857B2 (enExample) |
| EP (2) | EP2446895A1 (enExample) |
| JP (4) | JP2013540117A (enExample) |
| KR (2) | KR101719966B1 (enExample) |
| AU (1) | AU2011310109B2 (enExample) |
| CA (1) | CA2813101C (enExample) |
| DK (1) | DK2621513T3 (enExample) |
| ES (1) | ES2616444T3 (enExample) |
| NZ (1) | NZ609594A (enExample) |
| PL (1) | PL2621513T3 (enExample) |
| WO (1) | WO2012042021A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20171143A1 (es) | 2010-12-08 | 2017-08-10 | Stem Centrx Inc | Nuevos moduladores y metodos para su uso |
| SA112330278B1 (ar) | 2011-02-18 | 2015-10-09 | ستيم سينتركس، انك. | مواد ضابطة جديدة وطرق للاستخدام |
| EP2733206A1 (en) * | 2012-11-19 | 2014-05-21 | Naroa LLC | Method for the isolation for mammalian stem cells using EphA2 and uses thereof |
| AR098221A1 (es) | 2013-11-04 | 2016-05-18 | Pfizer | Conjugados de anticuerpo anti-efna4-fármaco |
| WO2015168019A2 (en) | 2014-04-30 | 2015-11-05 | Pfizer Inc. | Anti-ptk7 antibody-drug conjugates |
| JP6921755B2 (ja) * | 2014-12-10 | 2021-08-18 | ハイパーステム ソシエテ アノニム | 脳腫瘍幹細胞の成長、遊走および浸潤性を低下させ脳腫瘍患者の生存率を改善する方法および組成物 |
| US10783439B2 (en) * | 2015-05-08 | 2020-09-22 | FlowJo, LLC | Plugin interface and framework for integrating a remote server with sample data analysis software |
| IL289849B2 (en) | 2015-11-10 | 2024-01-01 | Nat Inst Biotechnology Negev Ltd | Means and methods for reducing tumorigenicity of cancer stem cells |
| CN115379845B (zh) * | 2020-03-31 | 2024-10-25 | 学校法人庆应义塾 | 使用了基因组编辑多能干细胞的治疗药 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005037233A2 (en) * | 2003-10-15 | 2005-04-28 | Medimmune, Inc. | Listeria-based epha2 vaccines |
| US20060040325A1 (en) * | 2004-08-16 | 2006-02-23 | Medimmune, Inc. | Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity |
| US20070248628A1 (en) * | 2005-12-06 | 2007-10-25 | Keller Lorraine H | Immunogens in cancer stem cells |
| US8343461B2 (en) * | 2006-03-08 | 2013-01-01 | Wake Forest University Health Sciences | Molecular signature of cancer |
| LT2199390T (lt) * | 2007-08-30 | 2017-03-10 | Daiichi Sankyo Company, Limited | Anti-epha2 antikūnas |
-
2010
- 2010-10-01 EP EP10185930A patent/EP2446895A1/en not_active Withdrawn
-
2011
- 2011-04-18 US US13/089,217 patent/US9078857B2/en active Active
- 2011-09-30 PL PL11778540T patent/PL2621513T3/pl unknown
- 2011-09-30 DK DK11778540.2T patent/DK2621513T3/en active
- 2011-09-30 CA CA2813101A patent/CA2813101C/en active Active
- 2011-09-30 KR KR1020167002577A patent/KR101719966B1/ko active Active
- 2011-09-30 NZ NZ609594A patent/NZ609594A/en unknown
- 2011-09-30 JP JP2013530753A patent/JP2013540117A/ja active Pending
- 2011-09-30 AU AU2011310109A patent/AU2011310109B2/en active Active
- 2011-09-30 KR KR1020137011310A patent/KR20130095286A/ko not_active Ceased
- 2011-09-30 WO PCT/EP2011/067114 patent/WO2012042021A1/en not_active Ceased
- 2011-09-30 EP EP11778540.2A patent/EP2621513B1/en active Active
- 2011-09-30 ES ES11778540.2T patent/ES2616444T3/es active Active
-
2015
- 2015-10-09 JP JP2015200808A patent/JP6523910B2/ja active Active
-
2017
- 2017-10-02 JP JP2017192907A patent/JP6618968B2/ja active Active
-
2019
- 2019-11-13 JP JP2019205190A patent/JP2020037579A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011310109A1 (en) | 2013-05-02 |
| KR101719966B1 (ko) | 2017-03-24 |
| WO2012042021A1 (en) | 2012-04-05 |
| JP6618968B2 (ja) | 2019-12-11 |
| EP2446895A1 (en) | 2012-05-02 |
| US20120083454A1 (en) | 2012-04-05 |
| JP2013540117A (ja) | 2013-10-31 |
| CA2813101C (en) | 2018-10-30 |
| DK2621513T3 (en) | 2017-03-06 |
| CA2813101A1 (en) | 2012-04-05 |
| JP2018048151A (ja) | 2018-03-29 |
| JP2020037579A (ja) | 2020-03-12 |
| KR20160027106A (ko) | 2016-03-09 |
| NZ609594A (en) | 2015-01-30 |
| ES2616444T3 (es) | 2017-06-13 |
| EP2621513A1 (en) | 2013-08-07 |
| KR20130095286A (ko) | 2013-08-27 |
| JP6523910B2 (ja) | 2019-06-05 |
| AU2011310109B2 (en) | 2014-11-20 |
| US9078857B2 (en) | 2015-07-14 |
| EP2621513B1 (en) | 2016-12-28 |
| JP2016094391A (ja) | 2016-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250234B (en) | Creating blood vessels using placental stem cells | |
| GB201017019D0 (en) | Cell selection | |
| EP2600904A4 (en) | ARTIFICIAL CELLS | |
| PT2785834T (pt) | Composição de células estaminais melhorada | |
| GB201000375D0 (en) | T Cell clonotypes | |
| EP2724644A4 (en) | CUSHION CELL AND CUSHION BODY USING THE SAME | |
| EP2601290A4 (en) | SOMATIC STEM CELLS | |
| PL2621513T3 (pl) | Ekspresja receptora eph w nowotworowych komórkach macierzystych | |
| GB201017421D0 (en) | Cell | |
| EP2760996A4 (en) | SOMATIC STEM CELLS | |
| IL237228A0 (en) | Stem cells that improve healing | |
| GB201001156D0 (en) | Photovoltaic cell | |
| IL236271A0 (en) | Marker quantification in single cells in tissue sections | |
| GB0920775D0 (en) | Cells | |
| GB2484455B (en) | Photovoltaic cells | |
| GB201014823D0 (en) | Solar cell | |
| GB201003466D0 (en) | Fuel cells | |
| GB201012052D0 (en) | Glyco-engineering in lower eukaryotic cells | |
| GB201112476D0 (en) | Glyco-engineering in lower eukaryotic cells | |
| GB201020580D0 (en) | Cells | |
| GB201019304D0 (en) | Cells | |
| EP2598166A4 (en) | CELLS WITHOUT CMH | |
| GB201019108D0 (en) | Cell | |
| GB0918471D0 (en) | Stem cells | |
| GB201010803D0 (en) | Photovoltaic cells |